Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
University of California, San Diego
Mayo Clinic
CHU de Reims
Universitätsklinikum Hamburg-Eppendorf
UNC Lineberger Comprehensive Cancer Center
Leiden University Medical Center
University Health Network, Toronto
Centre Hospitalier Universitaire de Saint Etienne
University of California, San Diego
Baptist Health South Florida
National Cancer Centre, Singapore
Universitätsklinikum Hamburg-Eppendorf
Laval University
Sichuan University
University of California, San Diego
Helsinki University Central Hospital
Columbia University
Changsha Medical University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Federation Francophone de Cancerologie Digestive
University Medical Center Groningen
Kaohsiung Medical University
Steba Biotech S.A.
UNICANCER
University of Chicago
UConn Health
Chinese University of Hong Kong
Latin American Cooperative Oncology Group
Washington University School of Medicine
Herlev Hospital
University of Kentucky
University of Kentucky
Oslo University Hospital
H. Lee Moffitt Cancer Center and Research Institute
Universitaire Ziekenhuizen KU Leuven
Qilu Hospital of Shandong University
Ludwig Institute for Cancer Research
H. Lee Moffitt Cancer Center and Research Institute
Ohio State University Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
Centre Hospitalier Universitaire de Nice
University of Florida
H. Lee Moffitt Cancer Center and Research Institute
Providence Health & Services
St. Joseph Hospital of Orange
University of California, San Diego
Tata Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Duke University